1. Home
  2. HURN vs AMRX Comparison

HURN vs AMRX Comparison

Compare HURN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURN
  • AMRX
  • Stock Information
  • Founded
  • HURN 2002
  • AMRX 2002
  • Country
  • HURN United States
  • AMRX United States
  • Employees
  • HURN N/A
  • AMRX N/A
  • Industry
  • HURN Professional Services
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HURN Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • HURN Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • HURN 2.6B
  • AMRX 2.4B
  • IPO Year
  • HURN 2004
  • AMRX N/A
  • Fundamental
  • Price
  • HURN $150.46
  • AMRX $7.41
  • Analyst Decision
  • HURN Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • HURN 5
  • AMRX 5
  • Target Price
  • HURN $158.60
  • AMRX $10.80
  • AVG Volume (30 Days)
  • HURN 240.0K
  • AMRX 2.1M
  • Earning Date
  • HURN 04-29-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • HURN N/A
  • AMRX N/A
  • EPS Growth
  • HURN 92.74
  • AMRX N/A
  • EPS
  • HURN 6.67
  • AMRX N/A
  • Revenue
  • HURN $1,525,814,000.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • HURN $11.10
  • AMRX $10.49
  • Revenue Next Year
  • HURN $6.72
  • AMRX $7.00
  • P/E Ratio
  • HURN $22.70
  • AMRX N/A
  • Revenue Growth
  • HURN 8.98
  • AMRX 13.42
  • 52 Week Low
  • HURN $84.87
  • AMRX $5.18
  • 52 Week High
  • HURN $153.85
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • HURN 63.36
  • AMRX 46.13
  • Support Level
  • HURN $122.32
  • AMRX $7.15
  • Resistance Level
  • HURN $154.83
  • AMRX $8.02
  • Average True Range (ATR)
  • HURN 4.98
  • AMRX 0.32
  • MACD
  • HURN 1.67
  • AMRX 0.02
  • Stochastic Oscillator
  • HURN 86.56
  • AMRX 31.07

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: